Abstract
BackgroundCirculating tumor DNA (ctDNA) can potentially provide a valuable tumor-specific and non-invasive biomarker for longitudinal monitoring of a patient’s response to therapy. We aimed to quantify HPV16 ctDNA in patients...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have